Cargando…

Comment: Ondansetron: Timing and dosage

Detalles Bibliográficos
Autores principales:	Hanumanthaiah, Deepak, Sudhir, Vinod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800352/ https://www.ncbi.nlm.nih.gov/pubmed/24163474 http://dx.doi.org/10.4103/0019-5049.118527

Ejemplares similares

Neuraxial block in a patient with dural ectasia
por: Hanumanthaiah, Deepak, et al.
Publicado: (2013)

Rate of administration of intravenous ondansetron
por: Prakash, Smita, et al.
Publicado: (2011)

Intraoperative pulseless ventricular tachycardia after Ondansetron
por: Samanta, Sukhen, et al.
Publicado: (2014)

Can we prevent ondansetron induced fatal ventricular tachycardia?
por: Swami, Onkar C.
Publicado: (2009)

Formulation and Characterization of Patient-Friendly Dosage Form of Ondansetron Hydrochloride
por: Bhoyar, PK, et al.
Publicado: (2010)

Ondansetron causing near fatal catastrophe in a renal transplant recipient
por: Sahu, Sandeep, et al.
Publicado: (2011)

Cardiac arrest associated with ranitidine and ondansetron combination in day care gynecologic surgery
por: Srivastava, Vinit K, et al.
Publicado: (2013)

The Effect of Ondansetron in Prevention of Postoperative Shivering after General Anesthesia in Gynecological Surgery
por: Entezari Asl, M, et al.
Publicado: (2012)

Effect of prophylactic ondansetron and/or continuous infusion of phenylephrine on spinal anesthesia-induced hypotension
por: Mhamdi, Salah, et al.
Publicado: (2018)

Should ondansetron be used as a routine prophylaxis agent for postoperative nausea and vomiting?
por: Kendall, Mark C., et al.
Publicado: (2018)

Novel potentiometric sensors for determination of ondansetron hydrochloride in pure and dosage form
por: Abass, Amina M., et al.
Publicado: (2021)

Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?
por: Blower, P, et al.
Publicado: (2002)

Reply: Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?
por: de Wit, R, et al.
Publicado: (2002)

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Response to comment on: Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Incorporating ondansetron and baclofen in alcohol use disorder treatment
por: Ross, Hayley, et al.
Publicado: (2023)

Comment: Intra-arterial chemotherapy for retinoblastoma
por: Kaur, Savleen, et al.
Publicado: (2017)

Authors’ Reply to Comments on ASHAs’ Perceptions on Depression
por: Mary Kapanee, Aruna Rose, et al.
Publicado: (2018)

A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form
por: Raval, P. B., et al.
Publicado: (2008)

Postoperative pharmacodynamic interaction of ondansetron; a 5-HT3 antagonist and paracetamol in patients operated in the ENT department under local anesthesia
por: Bhosale, Uma A., et al.
Publicado: (2014)

Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients
por: Lacout, Alexis, et al.
Publicado: (2021)

Comment on: Subspecialization in radiology – Is it time to hatch out of the cocoon?
por: Reddy, K Nihaal, et al.
Publicado: (2019)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Comment to: Teleconsultation of infant rheumatology in COVID-19 time
por: Qanneta, Rami
Publicado: (2023)

Response: Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single blind randomised trial
por: Ganjare, Ashish, et al.
Publicado: (2013)

Response to comments on: Retinal vein occlusion in COVID-19: A novel entity
por: Sheth, Jay U, et al.
Publicado: (2021)

Comments on editorial - Test of reversibility of airway obstruction: Time for review
por: Varudkar, H. G.
Publicado: (2013)

Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021)

Syringe label: A potential source of dosage error
por: Velayudhan, Savitri, et al.
Publicado: (2014)

Comments on: COVID-19 pandemic – Testing times for postgraduate medical education
por: Gurnani, Bharat, et al.
Publicado: (2021)

Comment on Repeat gas insufflation for successful closure of idiopathic macular hole following failed primary surgery
por: Takkar, Brijesh, et al.
Publicado: (2015)

Comment on Student-teacher research: A dilemma between power, ethics, and morality
por: Saxena, Deepak, et al.
Publicado: (2015)

Fentanyl can be mitochondrion -toxic depending on dosage and cell type
por: Finsterer, Josef, et al.
Publicado: (2019)

Margins of beneficial daily dosage of supplements in prevention of COVID-19
por: Ajdžanovic, Vladimir, et al.
Publicado: (2021)

Epinephrine Administered in Anaphylaxis: The Evolution of 0.3 mg Dosage
por: Coady, Peyton, et al.
Publicado: (2023)

Comment on “Vaccine, infection, COVID-19-related loss of training time and athletes”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
por: Fukumoto, Takeshi, et al.
Publicado: (2022)

Comment on editorial
por: Sarkar, H. S.
Publicado: (2013)

Editor's comment
por: Bhattacharya, S.
Publicado: (2011)

An Author's Comment
por: Frankenburg, Charis U.
Publicado: (1962)

Cannot write session to /tmp/vufind_sessions/sess_nh1qmp63a6daal43tj3370hgrh